Patent · US Active

Recombinant non-pathogenic marek's disease virus constructs encoding infectious laryngotracheitis virus and newcastle disease virus antigens

US8932604B2 · kind B2 · utility

5Cited by
25References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 19, 2012
Grant dateJan 13, 2015
Priority date
Expiry dateOct 19, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2760/18134
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Recombinant multivalent non-pathogenic Marek's Disease virus constructs that encode and express both Infectious Laryngotracheitis Virus and Newcastle Disease virus protein antigens, and methods of their use in poultry vaccines.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.